Impact of prior robotic surgical expertise on the results of Hugo RAS radical prostatectomy: a propensity score-matched comparison between Da Vinci-expert and non-Da Vinci-expert surgeons - Scorecard - MDSpire

Impact of prior robotic surgical expertise on the results of Hugo RAS radical prostatectomy: a propensity score-matched comparison between Da Vinci-expert and non-Da Vinci-expert surgeons

  • By

  • Filippo Gavi

  • Maria Chiara Sighinolfi

  • Daniele Fettucciari

  • Cristina Carerj

  • Filippo Marino

  • Enrico Panio

  • Pierluigi Russo

  • Nazario Foschi

  • Riccardo Bientinesi

  • Carlo Gandi

  • Giuseppe Palermo

  • Angelo Totaro

  • Emilio Sacco

  • Bernardo Rocco

  • April 20, 2025

  • 0 min

Share

Clinical Scorecard: Influence of Previous Robotic Surgery Experience on Outcomes of Hugo RAS Radical Prostatectomy

At a Glance

CategoryDetail
ConditionProstate cancer treated with robot-assisted radical prostatectomy
Key MechanismsUse of Hugo RAS robotic system for radical prostatectomy; comparison of outcomes based on surgeons' prior experience with Da Vinci robotic system
Target PopulationAdult patients undergoing radical prostatectomy for prostate cancer
Care SettingUrologic surgical department with access to Hugo RAS robotic platform

Key Highlights

  • No significant difference in positive surgical margin rates between surgeons experienced with Da Vinci and those without prior Da Vinci experience.
  • Operative time was shorter and estimated blood loss was lower in surgeons with prior Da Vinci experience.
  • Complication rates were low and similar regardless of prior robotic surgery experience.

Guideline-Based Recommendations

Diagnosis

  • Preoperative risk assessment including PSA levels and Briganti nomogram for nodal invasion risk.

Management

  • Radical prostatectomy performed using Hugo RAS system following Montsouris technique.
  • Selective lymph node dissection based on preoperative nodal invasion risk.

Monitoring & Follow-up

  • Postoperative follow-up up to 24 months including biochemical recurrence, continence, and potency assessments.
  • Use of Clavien-Dindo classification for complication monitoring.

Risks

  • Positive surgical margins and biochemical recurrence rates comparable between surgeon experience groups.
  • Potential for longer operative time and higher blood loss in surgeons without prior Da Vinci experience.

Patient & Prescribing Data

Patients undergoing robot-assisted radical prostatectomy with Hugo RAS system.

Surgeons with prior Da Vinci experience may achieve shorter operative times and lower blood loss, but oncological and safety outcomes are similar regardless of prior robotic experience.

Clinical Best Practices

  • Ensure surgeons receive specific dry- and wet-lab training on Hugo RAS system prior to clinical use.
  • Implement a supervised learning curve with expert surgeons present during initial cases.
  • Use propensity score matching to balance patient characteristics when comparing surgical outcomes.
  • Monitor perioperative outcomes including operative time, blood loss, complications, and oncological results.
  • Adopt standardized definitions for continence and potency to assess functional outcomes.

References

Original Source(s)

Related Content